With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Cell Line and Xenograft Repository||Texas Tech University Health Sciences Center / Patrick Reynolds, MD/PhD||Catalyst Grants||2014||Texas|
|Trk-Targeted Therapy of Human Neuroblastomas||Children's Hospital of Philadelphia / Garrett Brodeur, M.D.||Bridge Grants||2014||Pennsylvania|
|STAT3 Signaling Profiles Predict Response to Chemotherapy in Pediatric AML||Baylor College of Medicine / Michele Redell, M.D./Ph.D.||Springboard Grants||2014||Texas|
|Neurocognitive Assessments within COG: An Intensive, Integrated Model for Successfully Evaluating Children with High-Risk ALL||Children's Research Institute / Kristina Hardy, PhD||Psychosocial Grants||2014||District of Columbia|
|Development of a Screening Module to Assess Sibling-Related Psychosocial Risk in Families of Children with Cancer||Boston University / Kristin Long, PhD||Psychosocial Grants||2014||Massachusetts|
|HA-1 TCR T-cell Immunotherapy for Acute Leukemia||Fred Hutchinson Cancer Research Center / Marie Bleakley, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Washington|
|Phase I Trial of Indoximod in Combination with Temozolomide-based Therapy for Children with Progressive Primary Brain Tumors||Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Georgia|
|Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells||Baylor College of Medicine / Leonid S. Metelitsa, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Texas|
|Identification of Rhabdomyosarcoma Therapies Using an Efficient Mouse and Drosophila Repurposing Screen||Memorial Sloan-Kettering Cancer Center / Mary Baylies, Ph.D.||Reach Grants||2014||New York|
|Identifying Novel Therapeutic Combinations with 131I-MIBG to Treat Relapsed and Refractory Neuroblastoma||The Regents of the University of California San Francisco / William Clay Gustafson, M.D., Ph.D.||Reach Grants||2014||California|